The Real Two Week Deadlines
Tax and tariffs have real 2 week deadlines. Keep homebuilders for lower rates, but take profit in XLE. Nibble on cybersecurity as Trump urges NATO to spend.
192
0
0
Jun 22, 2025
The Real Two Week Deadlines
Tax and tariffs have real 2 week deadlines. Keep homebuilders for lower rates, but take profit in XLE. Nibble on cybersecurity as Trump urges NATO to spend.
192
0
0
Jun 22, 2025
Trump's Moment of Truth
July 9th: TACO trades vs Donald Trump. Wall Street has already placed its bet, but what could go wrong? What is the cheapest hedge against unilateral tariffs?
9
0
0
Friday, June 27, 2025


METHODOLOGY:
1: Excess returns are calculated daily using US closing prices.
2. Portfolios are rebalanced on Mondays at New York open, based on allocation strategies discussed in our Beat the Market video on Sunday.
3: The calibration of our risk exposure is based on our target of annual excess return of 250 basis points and information ratio of 2.
< 10 mins
Trump's Moment of Truth
July 9th: TACO trades vs Donald Trump. Wall Street has already placed its bet, but what could go wrong? What is the cheapest hedge against unilateral tariffs?
9
0
0
Friday, June 27, 2025
Sunday strategy video
30 mins
The Real Two Week Deadlines
Tax and tariffs have real 2 week deadlines. Keep homebuilders for lower rates, but take profit in XLE. Nibble on cybersecurity as Trump urges NATO to spend.
The Real Two Week Deadlines
Tax and tariffs have real 2 week deadlines. Keep homebuilders for lower rates, but take profit in XLE. Nibble on cybersecurity as Trump urges NATO to spend.
The Real Two Week Deadlines
Tax and tariffs have real 2 week deadlines. Keep homebuilders for lower rates, but take profit in XLE. Nibble on cybersecurity as Trump urges NATO to spend.
192
0
0
Sunday, June 22, 2025
Leverage without leverage
Warren Buffett and Peter Lynch tell us that diversification is bad. We explain what really happens when you diversify, and how we use it.

MORE BUYERS OR SELLERS?
Monday fast money
Chinese data suggests Covid testing is being reduced
Asymptomatic cases in China have begun to diverge from symptomatic cases.
